JP Morgan Maintains Overweight on Braze, Lowers Price Target to $34
JP Morgan analyst Alexei Gogolev maintains Braze (NASDAQ:BRZE) with a Overweight and lowers the price target from $35 to $34.
Share
Why It Matters
A big bank's expert still thinks Braze is good to own, but lowered their guess of what the stock might be worth from $35 to $34—a tiny change that suggests they're not worried, just being careful.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.